The Kunshan Elderly Health Study
KEHS
1 other identifier
observational
5,945
1 country
1
Brief Summary
The Kunshan Elderly Health Study (KEHS) is a community-based prospective cohort study of chronic disease, mortality and associated factors among elderly adults in Kunshan, Eastern China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 17, 2021
CompletedFirst Submitted
Initial submission to the registry
November 15, 2021
CompletedFirst Posted
Study publicly available on registry
December 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2032
April 22, 2024
April 1, 2024
11.6 years
November 15, 2021
April 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of chronic diseases
Chronic diseases including cardiovascular disease, diabetes, cancer, etc. will be identified by chronic disease registries and active follow-up
Trough study completion, an average of 10 years
Mortality
Total and cause-specific mortality
Trough study completion, an average of 10 years
Study Arms (1)
The Kunshan Elderly Health Study (KEHS)
Community-based observational cohort.
Interventions
Eligibility Criteria
Approximately 8,000 elderly residents (both men and women) aged 65 years and above in communities in Kunshan, Eastern China.
You may qualify if:
- Locally registered-residents in Kunshan
- Aged 65 years or above
- Voluntary agreement to participate in the study (with written informed consent)
You may not qualify if:
- Patients with stroke, coronary heart disease or cancer
- Patients with severe physical or mental illness
- People unable to complete the survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kunshan Center for Disease Control and Prevention
Kunshan, Jiangsu, 215301, China
Biospecimen
Plasma, serum, red blood cells and white blood cells.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hui Zuo, M.D., Ph.D.
Soochow University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 15, 2021
First Posted
December 2, 2021
Study Start
May 17, 2021
Primary Completion (Estimated)
December 31, 2032
Study Completion (Estimated)
December 31, 2032
Last Updated
April 22, 2024
Record last verified: 2024-04